Global 3D Cardiac Mapping Systems Market 2019-2023
The global 3D cardiac mapping systems market size will grow by USD
412.6 million during 2019-2023. This report offers an analysis of the
market based on product (contact 3D cardiac mapping systems and
non-contact 3D cardiac mapping systems) and geography (Asia, Europe,
North America, and ROW). The 3D cardiac mapping systems market research
report further analyzes the market’s competitive landscape and offers
information on several companies including Abbott, Boston Scientific
Corporation, Johnson & Johnson Services, Inc., Medtronic, and
MicroPort Scientific Corporation.
To identify growth opportunities in the 3D cardiac mapping systems market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Asia and ROW will grow faster than the overall market. The growth of Europe and North America will be slower than the global market.
Below are some of the key findings from this 3D cardiac mapping systems market research report
Moreover, the emergence of non-invasive 3D cardiac mapping systems will gain prominence in the market. Non-invasive cardiac mapping reduces mapping times by offering information on the topography of arrhythmogenic foci before the procedure. These devices also enable continuous and simultaneous panoramic mapping of both atria or both ventricles which cannot be achieved with current invasive methods. This will also help clinicians in streamlining the clinical procedure planning process. This coupled with the growing prevalence of cardiac arrhythmias and related risk factors will drive 3D cardiac mapping systems market growth at a CAGR of about 10% during the forecast period.
To identify growth opportunities in the 3D cardiac mapping systems market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Asia and ROW will grow faster than the overall market. The growth of Europe and North America will be slower than the global market.
Below are some of the key findings from this 3D cardiac mapping systems market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global 3D cardiac mapping systems industry overview
The increasing prevalence of cardiac arrhythmias and related risk factors will drive the 3D cardiac mapping systems market growth in the coming years. Because of the increased risk of stroke and hospitalizations, the prevalence of cardiac arrhythmias has increased steadily in recent years. This has caused various health-conscious people across the globe to purchase devices for the early detection and treatment of cardiac arrhythmias. This will subsequently drive the growth of 3D cardiac mapping systems market.Moreover, the emergence of non-invasive 3D cardiac mapping systems will gain prominence in the market. Non-invasive cardiac mapping reduces mapping times by offering information on the topography of arrhythmogenic foci before the procedure. These devices also enable continuous and simultaneous panoramic mapping of both atria or both ventricles which cannot be achieved with current invasive methods. This will also help clinicians in streamlining the clinical procedure planning process. This coupled with the growing prevalence of cardiac arrhythmias and related risk factors will drive 3D cardiac mapping systems market growth at a CAGR of about 10% during the forecast period.
Comments
Post a Comment